Venlo, the Netherlands, June 23, 2020 – QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) announces that according to the intended business combination between Invitae (NYSE: NVTA) and ArcherDX, QIAGEN could realize a significant pre-tax capital gain from its minority investment in ArcherDX, a U.S.-based genomics analysis company involved in precision oncology. As of June... Read more
COLUMBUS, Ohio (June, 2020) – The 870 Auto Wrapper is METTLER TOLEDO’s newest machine for weighing, wrapping and labeling in backroom environments. With the 870 Auto Wrapper, METTLER TOLEDO is responding to the needs of grocery retailers who are looking for a robust and economical automated wrapping station – one that can cope with the... Read more
Agreement centers on identifying HER2 gene mutations using Oncomine Dx Target Test Read more
SAN DIEGO–(BUSINESS WIRE)–Illumina, Inc. (NASDAQ:ILMN) has selected seven early-stage companies to join the first global cohort of Illumina Accelerator, the company creation engine focused on partnering with entrepreneurs to build breakthrough genomics startups. Three companies comprise the inaugural funding cycle of Illumina Accelerator Cambridge, UK and four companies will join as part of the 11th... Read more
Venlo, the Netherlands, June 22, 2020 – QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) announced today that it plans to provide in the first half of July 2020 an overview of preliminary results for the second quarter and first half of 2020, along with perspectives on anticipated business trends for the third quarter of... Read more
A new, faster strategy uses scanning electron microscopy for ultrastructural imaging of large tissue sections Electron microscopy is an essential tool for pathologists, providing high resolution imaging of tissue structures, cells, organelles and microbes. However, ultrastructural analyses of large areas of tissue can be challenging and time consuming. Dr. Mike Reichelt, Principle Scientific Researcher at... Read more
·Phase III IPATential150 study evaluating ipatasertib in combination with abiraterone and prednisone/prednisolone compared to current standard-of-care (abiraterone and prednisone/prednisolone alone) plus placebo met its co-primary endpoint of radiographic progression free survival (rPFS) in patients with PTEN loss tumours Basel, 19 June 2020 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the phase III... Read more
Chalfont St Giles, UK, June 18, 2020 – GE Healthcare today introduced its Thoracic Care Suite, a collection of eight artificial intelligence (AI) algorithms from Lunit Insight CXR to help alleviate clinical strain due to COVID-19. The AI suite quickly analyzes chest x-ray findings and flags abnormalities to radiologists for review, including pneumonia, which may... Read more
Initiative to enhance newborn screening in underserved populations for improved health outcomes in Africa WALTHAM, Mass. – June 18, 2020 – PerkinElmer, Inc. (NYSE:PKI), a global leader committed to innovating for a healthier world, today announced a collaboration with the American Society of Hematology (ASH), the world’s largest professional society of hematologists, to support a... Read more
IMpassion031 data will be discussed with health authorities globally, including the US Food and Drug Administration and the European Medicines Agency Tecentriq is the only approved cancer immunotherapy for the treatment of metastatic triple-negative breast cancer, a very aggressive and difficult-to-treat form of breast cancer Basel, 18 June 2020 – Roche (SIX: RO, ROG; OTCQX:... Read more